Herzuma-capecitabine/Cisplatin for Gastric Cancer

Clinical trial NCT03588533 · UNKNOWN

Trial details

NCT number: NCT03588533
Sponsor: Sung Yong Oh
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

HER-2 Positive Gastric Cancer Metastatic Cancer

Start date: 2018-06-10
Primary completion: 2019-08-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.